Clinical Trial Update: Evaluation of Doxycycline Post-exposure Prophylaxis to Reduce Sexually Transmitted Infections in PrEP Users and HIV-infected Men Who Have Sex With Men [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating doxycycline post-exposure prophylaxis to prevent gonorrhea, chlamydia, and syphilis among PrEP users and HIV-infected men who have sex …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chlamydia
• Gonorrhea
• Syphilis

Drugs mentioned

• Doxycycline (Doxycycline)

Snippet

Sponsor: University of California, San Francisco | Conditions: Gonorrhea, Chlamydia | Phase 4 | Status: COMPLETED | Results posted: 2024-07-12